EP0586812A3 - Médicaments contenant de la glicentin comme ingrédient actif. - Google Patents

Médicaments contenant de la glicentin comme ingrédient actif. Download PDF

Info

Publication number
EP0586812A3
EP0586812A3 EP19930110400 EP93110400A EP0586812A3 EP 0586812 A3 EP0586812 A3 EP 0586812A3 EP 19930110400 EP19930110400 EP 19930110400 EP 93110400 A EP93110400 A EP 93110400A EP 0586812 A3 EP0586812 A3 EP 0586812A3
Authority
EP
European Patent Office
Prior art keywords
glicentin
medicaments
active ingredient
ingredient
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP19930110400
Other languages
German (de)
English (en)
Other versions
EP0586812A2 (fr
EP0586812B1 (fr
Inventor
Akira Ohneda
Kazuyuki Sasaki
Yohei Natori
Tomohisa Nagasaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nisshin Seifun Group Inc
Original Assignee
Nisshin Seifun Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nisshin Seifun Group Inc filed Critical Nisshin Seifun Group Inc
Publication of EP0586812A2 publication Critical patent/EP0586812A2/fr
Publication of EP0586812A3 publication Critical patent/EP0586812A3/fr
Application granted granted Critical
Publication of EP0586812B1 publication Critical patent/EP0586812B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP93110400A 1992-07-13 1993-06-30 Médicaments contenant de la glicentin comme ingrédient actif Expired - Lifetime EP0586812B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP185066/92 1992-07-13
JP18506692 1992-07-13
JP18506692 1992-07-13

Publications (3)

Publication Number Publication Date
EP0586812A2 EP0586812A2 (fr) 1994-03-16
EP0586812A3 true EP0586812A3 (fr) 1994-12-07
EP0586812B1 EP0586812B1 (fr) 2000-01-05

Family

ID=16164215

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93110400A Expired - Lifetime EP0586812B1 (fr) 1992-07-13 1993-06-30 Médicaments contenant de la glicentin comme ingrédient actif

Country Status (5)

Country Link
US (2) US5616558A (fr)
EP (1) EP0586812B1 (fr)
KR (1) KR940005283A (fr)
CA (1) CA2099476A1 (fr)
DE (1) DE69327495T2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2961045B2 (ja) * 1993-02-24 1999-10-12 日清製粉株式会社 腸管粘膜増強促進剤
JP2814892B2 (ja) * 1993-10-18 1998-10-27 日清製粉株式会社 消化管運動抑制剤
JP2887063B2 (ja) * 1993-12-28 1999-04-26 日清製粉株式会社 グリセンチンの製造方法
US5702922A (en) 1994-11-29 1997-12-30 Nisshin Flour Milling Co., Ltd. Method for the extraction of glicentin or glicentin analogous substances
US6335317B1 (en) 1998-04-10 2002-01-01 Emory University Use of gut-trophic growth factors to improve oxidative status
JP4149713B2 (ja) * 2002-02-22 2008-09-17 全司 岡田 感染症治療剤
US8288509B2 (en) 2002-02-22 2012-10-16 National Hospital Organization Kinki-chuo Chest Medical center Therapeutic agent for infections, and treatment method using the same
US20040115754A1 (en) * 2002-12-11 2004-06-17 Umax Data Systems Inc. Method for establishing a long-term profile of blood sugar level aiding self-control of the same
TW200411178A (en) * 2002-12-31 2004-07-01 Veutron Corp Method for determining the resolution of blood glucose by using rising time curve
TW592667B (en) * 2003-04-04 2004-06-21 Veutron Corp Method for determining the resolution of blood glucose

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990011296A1 (fr) * 1989-03-20 1990-10-04 The General Hospital Corporation Hormone insulinotrope

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US5118666A (en) * 1986-05-05 1992-06-02 The General Hospital Corporation Insulinotropic hormone

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990011296A1 (fr) * 1989-03-20 1990-10-04 The General Hospital Corporation Hormone insulinotrope

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 105, no. 17, 27 October 1986, Columbus, Ohio, US; abstract no. 146676h, OHNEDA A. ET AL.: "Effect of glicentin-related peptides on glucagon secretion in anesthetized dogs" page 115; *
CHEMICAL ABSTRACTS, vol. 94, no. 7, 16 February 1981, Columbus, Ohio, US; abstract no. 41670c, AHREN B. ET AL.: "Effects of glicentine on insulin secretion" page 69; *
DIABETOLOGICA, vol. 29, no. 6, 1986, pages 397 - 401 *
HOLST ET AL.: "Truncated glucagon-like peptide I, an insulin-releasing hormon from the distal gut", FEBS LETTERS, vol. 211, no. 2, January 1987 (1987-01-01), AMSTERDAM NL, pages 169 - 174 *
HORM. METAB. RES., vol. 12, no. 11, 1980, pages 582 - 586 *

Also Published As

Publication number Publication date
DE69327495T2 (de) 2000-06-15
DE69327495D1 (de) 2000-02-10
EP0586812A2 (fr) 1994-03-16
US5700776A (en) 1997-12-23
EP0586812B1 (fr) 2000-01-05
US5616558A (en) 1997-04-01
CA2099476A1 (fr) 1994-01-14
KR940005283A (ko) 1994-03-21

Similar Documents

Publication Publication Date Title
GR3025363T3 (en) Medicaments.
EP0645136A3 (fr) Préparation pharmaceutique du type: substance physiologiquement active à libération prolongée.
EP0653204A3 (fr) Formulations d'aérosols à usage médical.
GR3036937T3 (en) Pharmaceutical formulations.
ZA965866B (en) 6-Dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
ZA9610650B (en) 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
HUP0100059A3 (en) Novel pyridazine derivatives and drugs containing the same as the active ingredient
ZA914957B (en) Aerosol drug formulations
ZA926020B (en) Pharmaceutical combination formulation.
PH30982A (en) Optically active 5H-pyrrolo Ä3,4-bÜ pyrazine derivative, its preparation and pharmaceutical compositions containing it.
EP0671911A4 (fr) Derives de carboxy-peptidyle utilises comme agents anti-degeneratifs actifs.
AU1792492A (en) Phellodendrine analogs and allergy type iv suppressor containing the same as active ingredient
EG20417A (en) Dihalopropene compounds insecticide acaricide containing same as active ingredient
HUT71740A (en) 2-fluoroalkyl-substituted benzimidazoles, their preparation and their use as insecticides
EG20222A (en) An oxazoline compound its production and insecticides and/or acoricides containing the same as an active ingredient
EP0586812A3 (fr) Médicaments contenant de la glicentin comme ingrédient actif.
ZA931066B (en) Liquid pesticidal formulations.
ZA927506B (en) New drug formulation.
AP9300592A0 (en) Medicaments
AU662651B2 (en) Sulfamoyltriazole derivative and bactericide containing the same as active ingredient
GB9201639D0 (en) Pharmaceutical formulations
AU2576695A (en) Antiviral agent containing benzodithiin derivative as active ingredient
AU4982693A (en) Amide compound and plant disease control agent containing the same as active ingredient
IL111034A0 (en) Hydrazone compound and insecticide containing the same as active ingredient
EP0987244A4 (fr) Derives de l'iodopropargyle et agents antimicrobiens les contenant comme principe actif

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19931014

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): BE CH DE DK FR GB IT LI NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): BE CH DE DK FR GB IT LI NL SE

17Q First examination report despatched

Effective date: 19980519

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

RIC1 Information provided on ipc code assigned before grant

Free format text: 6A 61K 38/02 A, 6C 07K 14/605 -

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): BE CH DE DK FR GB IT LI NL SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: THE PATENT HAS BEEN ANNULLED BY A DECISION OF A NATIONAL AUTHORITY

Effective date: 20000105

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20000105

Ref country code: LI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20000105

Ref country code: CH

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20000105

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20000105

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 38/22 A, 7C 07K 14/605 -

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REF Corresponds to:

Ref document number: 69327495

Country of ref document: DE

Date of ref document: 20000210

ET Fr: translation filed
ITF It: translation for a ep patent filed

Owner name: BIANCHETTI - BRACCO - MINOJA S.R.L.

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20000405

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DK

Payment date: 20000613

Year of fee payment: 8

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

REG Reference to a national code

Ref country code: FR

Ref legal event code: CD

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20050608

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20050623

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20050629

Year of fee payment: 13

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060630

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20060630

Year of fee payment: 14

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070103

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20060630

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20070228

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070630